Journal
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
Volume 134, Issue 5, Pages 535-541Publisher
SPRINGER
DOI: 10.1007/s00432-007-0316-8
Keywords
hepatocellular carcinoma; Bmi-1; expression; immunohistochemical analysis; prognosis
Categories
Ask authors/readers for more resources
Purpose Recent studies have identified polycomb-group gene Bmi-1 as oncogene in the generation of mouse pre-cell lymphomas, and overexpression of Bmi-1 has been found in several human tumor with the disease progress and poor prognosis of the cancer patients. Methods In present study, we investigated Bmi-1 expression and its prognostic significance in hepatocellular carcinoma (HCC) by performing immunohistochemical analysis, using a total of 137 HCC clinical tissue samples. Results High Bmi-1 expression (Bmi-1 2+ or 3+) was shown in 29.9% cases. The positive immuno-staining of Bmi-1 was not only in well/moderately-differentiated tumor cells, but also in surrounding noncancerous or cirrhotic liver tissue. Bmi-1 expression level did not correlate with any clinicopathological parameters. However, survival analysis showed that the high-Bmi-1 group had a significantly shorter overall survival time than the low-Bmi-1 group (P = 0.047). Multivariate analysis after 24 months revealed that Bmi-1 expression was a significant and independent prognostic parameter (P = 0.002) for HCC patients. Conclusion Our study indicated that Bmi-1 could be a candidate biomarker for long-term survival in HCC.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available